Cargando…

Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS

OBJECTIVE: We aimed to present the study design and baseline cross-sectional participant characteristics of biobank innovations for chronic cerebrovascular disease with Alzheimer’s disease study (BICWALZS) participants. METHODS: A total of 1,013 participants were enrolled in BICWALZS from October 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Hyun Woong, Kim, Na-Rae, Lee, Dong-gi, Cheong, Jae-Youn, Seo, Sang Won, Choi, Seong Hye, Kim, Eun-Joo, Cho, Soo Hyun, Kim, Byeong C., Kim, Seong Yoon, Kim, Eun Young, Chang, Jaerak, Lee, Sang Yoon, Yoon, Dukyong, Choi, Jin Wook, An, Young-Sil, Kang, Hee Young, Shin, Hyunjung, Park, Bumhee, Son, Sang Joon, Hong, Chang Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898610/
https://www.ncbi.nlm.nih.gov/pubmed/35042283
http://dx.doi.org/10.30773/pi.2021.0335
_version_ 1784663693482524672
author Roh, Hyun Woong
Kim, Na-Rae
Lee, Dong-gi
Cheong, Jae-Youn
Seo, Sang Won
Choi, Seong Hye
Kim, Eun-Joo
Cho, Soo Hyun
Kim, Byeong C.
Kim, Seong Yoon
Kim, Eun Young
Chang, Jaerak
Lee, Sang Yoon
Yoon, Dukyong
Choi, Jin Wook
An, Young-Sil
Kang, Hee Young
Shin, Hyunjung
Park, Bumhee
Son, Sang Joon
Hong, Chang Hyung
author_facet Roh, Hyun Woong
Kim, Na-Rae
Lee, Dong-gi
Cheong, Jae-Youn
Seo, Sang Won
Choi, Seong Hye
Kim, Eun-Joo
Cho, Soo Hyun
Kim, Byeong C.
Kim, Seong Yoon
Kim, Eun Young
Chang, Jaerak
Lee, Sang Yoon
Yoon, Dukyong
Choi, Jin Wook
An, Young-Sil
Kang, Hee Young
Shin, Hyunjung
Park, Bumhee
Son, Sang Joon
Hong, Chang Hyung
author_sort Roh, Hyun Woong
collection PubMed
description OBJECTIVE: We aimed to present the study design and baseline cross-sectional participant characteristics of biobank innovations for chronic cerebrovascular disease with Alzheimer’s disease study (BICWALZS) participants. METHODS: A total of 1,013 participants were enrolled in BICWALZS from October 2016 to December 2020. All participants underwent clinical assessments, basic blood tests, and standardized neuropsychological tests (n=1,013). We performed brain magnetic resonance imaging (MRI, n=817), brain amyloid positron emission tomography (PET, n=713), single nucleotide polymorphism microarray chip (K-Chip, n=949), locomotor activity assessment (actigraphy, n=200), and patient-derived dermal fibroblast sampling (n=175) on a subset of participants. RESULTS: The mean age was 72.8 years, and 658 (65.0%) were females. Based on clinical assessments, total of 168, 534, 211, 80, and 20 had subjective cognitive decline, mild cognitive impairment (MCI), Alzheimer’s dementia, vascular dementia, and other types of dementia or not otherwise specified, respectively. Based on neuroimaging biomarkers and cognition, 199, 159, 78, and 204 were cognitively normal (CN), Alzheimer’s disease (AD)-related cognitive impairment, vascular cognitive impairment, and not otherwise specified due to mixed pathology (NOS). Each group exhibited many differences in various clinical, neuropsychological, and neuroimaging results at baseline. Baseline characteristics of BICWALZS participants in the MCI, AD, and vascular dementia groups were generally acceptable and consistent with 26 worldwide dementia cohorts and another independent AD cohort in Korea. CONCLUSION: The BICWALZS is a prospective and longitudinal study assessing various clinical and biomarker characteristics in older adults with cognitive complaints. Details of the recruitment process, methodology, and baseline assessment results are described in this paper.
format Online
Article
Text
id pubmed-8898610
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Neuropsychiatric Association
record_format MEDLINE/PubMed
spelling pubmed-88986102022-03-11 Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS Roh, Hyun Woong Kim, Na-Rae Lee, Dong-gi Cheong, Jae-Youn Seo, Sang Won Choi, Seong Hye Kim, Eun-Joo Cho, Soo Hyun Kim, Byeong C. Kim, Seong Yoon Kim, Eun Young Chang, Jaerak Lee, Sang Yoon Yoon, Dukyong Choi, Jin Wook An, Young-Sil Kang, Hee Young Shin, Hyunjung Park, Bumhee Son, Sang Joon Hong, Chang Hyung Psychiatry Investig Original Article OBJECTIVE: We aimed to present the study design and baseline cross-sectional participant characteristics of biobank innovations for chronic cerebrovascular disease with Alzheimer’s disease study (BICWALZS) participants. METHODS: A total of 1,013 participants were enrolled in BICWALZS from October 2016 to December 2020. All participants underwent clinical assessments, basic blood tests, and standardized neuropsychological tests (n=1,013). We performed brain magnetic resonance imaging (MRI, n=817), brain amyloid positron emission tomography (PET, n=713), single nucleotide polymorphism microarray chip (K-Chip, n=949), locomotor activity assessment (actigraphy, n=200), and patient-derived dermal fibroblast sampling (n=175) on a subset of participants. RESULTS: The mean age was 72.8 years, and 658 (65.0%) were females. Based on clinical assessments, total of 168, 534, 211, 80, and 20 had subjective cognitive decline, mild cognitive impairment (MCI), Alzheimer’s dementia, vascular dementia, and other types of dementia or not otherwise specified, respectively. Based on neuroimaging biomarkers and cognition, 199, 159, 78, and 204 were cognitively normal (CN), Alzheimer’s disease (AD)-related cognitive impairment, vascular cognitive impairment, and not otherwise specified due to mixed pathology (NOS). Each group exhibited many differences in various clinical, neuropsychological, and neuroimaging results at baseline. Baseline characteristics of BICWALZS participants in the MCI, AD, and vascular dementia groups were generally acceptable and consistent with 26 worldwide dementia cohorts and another independent AD cohort in Korea. CONCLUSION: The BICWALZS is a prospective and longitudinal study assessing various clinical and biomarker characteristics in older adults with cognitive complaints. Details of the recruitment process, methodology, and baseline assessment results are described in this paper. Korean Neuropsychiatric Association 2022-02 2022-01-19 /pmc/articles/PMC8898610/ /pubmed/35042283 http://dx.doi.org/10.30773/pi.2021.0335 Text en Copyright © 2022 Korean Neuropsychiatric Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Roh, Hyun Woong
Kim, Na-Rae
Lee, Dong-gi
Cheong, Jae-Youn
Seo, Sang Won
Choi, Seong Hye
Kim, Eun-Joo
Cho, Soo Hyun
Kim, Byeong C.
Kim, Seong Yoon
Kim, Eun Young
Chang, Jaerak
Lee, Sang Yoon
Yoon, Dukyong
Choi, Jin Wook
An, Young-Sil
Kang, Hee Young
Shin, Hyunjung
Park, Bumhee
Son, Sang Joon
Hong, Chang Hyung
Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
title Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
title_full Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
title_fullStr Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
title_full_unstemmed Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
title_short Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
title_sort baseline clinical and biomarker characteristics of biobank innovations for chronic cerebrovascular disease with alzheimer’s disease study: bicwalzs
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898610/
https://www.ncbi.nlm.nih.gov/pubmed/35042283
http://dx.doi.org/10.30773/pi.2021.0335
work_keys_str_mv AT rohhyunwoong baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT kimnarae baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT leedonggi baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT cheongjaeyoun baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT seosangwon baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT choiseonghye baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT kimeunjoo baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT chosoohyun baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT kimbyeongc baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT kimseongyoon baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT kimeunyoung baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT changjaerak baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT leesangyoon baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT yoondukyong baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT choijinwook baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT anyoungsil baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT kangheeyoung baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT shinhyunjung baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT parkbumhee baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT sonsangjoon baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs
AT hongchanghyung baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs